Jasminelle (Drospirenone, Ethinylestradiol)

Drospirenone/Ethinylestradiol, the active ingredient in Jasminelle, is a combined oral contraceptive presented as a tablet for oral use. It works by inhibiting ovulation and altering cervical mucus to prevent pregnancy in women of reproductive age.

GNH USA supplies Jasminelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and adhering to EU manufacturing standards.

Jasminelle, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed. Regulation of menstrual cycle: helps establish more predictable bleeding patterns. Reduction of ovarian cysts: decreases the incidence of functional ovarian cyst formation.

Jasminelle may cause a range of adverse reactions. Users should be aware of both common and less frequent but serious events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional mild to moderate headaches. - Spotting: irregular light bleeding between periods. - Mood changes: fluctuations in emotional state. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Hypertension: elevated blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Gallbladder disease: formation of gallstones. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Jasminelle, clinicians should evaluate patient history and risk factors.

Contraindications: avoid use in women with a history of thromboembolic disorders. Smoking: do not use in patients over 35 who smoke cigarettes. Medication review: assess concomitant use of enzyme‑inducing drugs that may reduce efficacy. Pregnancy: discontinue immediately if pregnancy is confirmed. Breastfeeding: consult a healthcare provider before use. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture and light.

Jasminelle can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine) may markedly reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin) may have altered anticoagulant effect. - Certain antiepileptics (e.g., phenobarbital) can decrease hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals such as fluconazole may increase hormone concentrations. - Some antiretrovirals (e.g., protease inhibitors) can affect metabolism. - Herbal supplements like St. John’s wort may reduce contraceptive effectiveness.